Quinolines as a novel structural class of potent and selective PDE4 inhibitors. Optimisation for inhaled administration-Reference-Cited by-同舟云学术

Quinolines as a novel structural class of potent and selective PDE4 inhibitors. Optimisation for inhaled administration

Published:2009-09 Issue:17 Volume:19 Page:5261-5265
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Woodrow Michael D.,Ballantine Stuart P.,Barker Michael D.,Clarke Beth J.,Dawson John,Dean Tony W.,Delves Christopher J.,Evans Brian,Gough Sharon L.,Guntrip Steven B.,Holman Stuart,Holmes Duncan S.,Kranz Michael,Lindvaal Mika K.,Lucas Fiona S.,Neu Margarete,Ranshaw Lisa E.,Solanke Yemisi E.,Somers Don O.,Ward Peter,Wiseman Joanne O.

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference17 articles.

1. Keynote review: Phosphodiesterase-4 as a therapeutic target

2. Novel 5,6-dihydropyrazolo-[3,4-E][1,4]diazepin-4 (1H)-one derivatives for the treatment of asthma and chronic obstructive pulmonary disease

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rhodium-catalyzed three-component C(sp³)/C(sp²)–H activation enabled by a two-fold directing group strategy;Chemical Communications;2024

2. New quinoline-based PDE4 inhibitors through GSK-256066 fragment-based elaboration;Journal of Molecular Structure;2024-01

3. Application of automated machine learning in the identification of multi‐target‐directed ligands blocking PDE4B, PDE8A, and TRPA1 with potential use in the treatment of asthma and COPD;Molecular Informatics;2023-06-16

4. Scouting Different Phosphodiesterase 4 Inhibitor Chemotypes in Silico To Guide the Design of Anti‐inflammatory/Antioxidant Agents;ChemMedChem;2023-03-10

5. An Empirical Quantitative Structure-Activity Relationship Equation Assists the Discovery of High-Affinity Phosphodiesterase 4D Inhibitors as Leads to PET Radioligands;Journal of Medicinal Chemistry;2023-01-06